GLOBAL BOTULINUM TOXIN MARKET FORECAST 2021-2028

Inkwood Research anticipates that the global botulinum toxin market will reach $4786.23 million by 2028, growing at a CAGR of 5.14% during the forecast period. The base year considered for the market study is 2020 and the forecast years are from 2021 to 2028.

botulinum-toxin-market

Key drivers fueling the global botulinum toxin market growth are:

  • Increasing demand for aesthetic procedures
  • Expansion of botulinum toxin into therapeutic applications
    • The increasing demand for modern beauty standards has generated a massive growth platform for botulinum toxin products across the world.
    • Therapeutic applications for botulinum toxin provide the market with lucrative growth opportunities through the healthcare platform.
    • The number of product launches worldwide continues to observe a subsequent rise, owing to the high demand for botulinum toxin. For instance, in January 2019, in South Korea, HuonsCo Ltd launched botulinum toxin products Liztox, designed to specifically treat forehead wrinkles.

Key growth restraining factors:

  • Adverse effects associated with botulinum toxin
  • Lack of reimbursement policies supporting cosmetic procedures
    • The upgrades and incessant changes in reimbursement policies are among the chief factors limiting the growth of the botulinum toxin market.
    • Moreover, current trends such as reimbursement, healthcare, coverage reform, payer, and provider consolidation, and escalating healthcare costs will allow lesser adoption of the newer advanced botulinum toxin products and thus, impede the market growth.
    • The lack of harmonization of the reimbursement policies restrains the botulinum toxin market growth. For instance, according to a research article by Dirk Dressler et al., published in the Journal of Clinical Movement Disorders 2017, botulinum toxin therapy is costly. In this regard, Dysport used in the treatment for one patient with widespread dystonia or spasticity may cost over EUR 2,000.
  • Lack of interchangeability between botulinum toxin products

The report scope of the global botulinum toxin market covers the segmentation analysis of type, application, and end-user.

Market by End-User:

  • Hospitals
  • Clinics and Others
    • Clinics and others is set to be the fastest-growing end-user during the forecasted period.
    • Since the application of botox does not require long-term care and significant ancillary services, aesthetic clinics are becoming the preferred location for cosmetic botulinum toxin procedures. Moreover, these clinics specialize in cosmetic minimally invasive procedures and also offer advantages like lower procedural cost and reduced wait times.
    • Standalone clinics and aesthetic centers are often associated with increased convenience and deliver eminent personalization and care scheduling-related options to the consumers. The establishments are essentially changing how people receive such aesthetic treatments, and are thus expected to register robust growth, especially in developing countries.

Geographically, the global botulinum toxin market has been segmented on the basis of four major regions, which includes:

  • North America: The United States and Canada
    • North America held the largest market share in 2020.
    • The increasing demand for non-invasive aesthetic procedures and the rising geriatric population primarily drive the region’s market over the forecast period.
    • The elderly population’s need for efficient facial rejuvenating products in order to delay the appearance of aging is expected to increase the demand for botulinum toxin.
  • Europe: The United Kingdom, Germany, France, Italy, Russia, Belgium, Poland, and Rest of Europe
  • Asia-Pacific: China, Japan, India, South Korea, Indonesia, Thailand, Vietnam, Australia & New Zealand, and Rest of Asia-Pacific
  • Rest of World: Latin America, the Middle East & Africa

Major players operating in the global botulinum toxin market:

  • AbbVie Inc (Allergan)
  • Merz Pharma
  • Galderma SA
  • Evolus Inc
  • US WorldMeds LLC
  • Others

Key strategies adopted by some of these companies;

In June 2020, Merz received approval from Japan’s Ministry of Health, Labor, and Welfare to market Xeomin (Incobotulinumtoxin A) for intramuscular injection in 50, 100, or 200 units for the treatment of upper limb spasticity. In June 2020, Allergan announced the Food and Drug Administration (FDA) approval of its expanded Botox (Onabotulinumtoxin A) label to treat pediatric patients with spasticity.

Key trends of the global botulinum toxin market:

  • Type B is the fastest-growing type in the market.
  • The forehead lines segment, under the cosmetic applications category, is likely to grow with the highest CAGR of xx% during the forecasted period.
  • In terms of the non-cosmetic applications category, the dystonia segment is set to hold the highest market share over the forecasting years.
  • The rise in medical tourism and the increasing aging population provides the global botulinum toxin market with significant expansion opportunities.

 

Frequently Asked Questions (FAQs):

OnabotulinumtoxinA (Botox) is the only drug used for the prophylactic treatment of chronic migraines.
The other cosmetic applications of botulinum toxin include facial lines, eyebrow lift, gummy smile, smile lift, and upper lip lines, jawlines, and facial slimming.
Low doses of botulinum toxin temporarily paralyze muscles, thereby benefiting patients with several types of dystonia.
TABLE OF CONTENTS
  1. RESEARCH SCOPE & METHODOLOGY
    1. STUDY OBJECTIVES
    2. SCOPE OF STUDY
    3. METHODOLOGY
    4. ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    1. MARKET SIZE & ESTIMATES
    2. MARKET OVERVIEW
  3. MARKET DYNAMICS
    1. RELATED MARKET ANALYSIS: AESTHETIC FILLER MARKET
    2. KEY DRIVERS
      1. INCREASING DEMAND FOR AESTHETIC PROCEDURES
      2. EXPANSION OF BOTULINUM TOXIN INTO THERAPEUTIC APPLICATIONS
    3. KEY RESTRAINTS
      1. ADVERSE EFFECTS ASSOCIATED WITH BOTULINUM TOXIN
      2. LACK OF REIMBURSEMENT POLICIES SUPPORTING COSMETIC PROCEDURES
      3. LACK OF INTERCHANGEABILITY BETWEEN BOTULINUM TOXIN PRODUCTS
  4. KEY ANALYTICS
    1. IMPACT OF COVID-19 ON BOTULINUM TOXIN MARKET
    2. KEY MARKET TRENDS
    3. PORTER’S FIVE FORCES ANALYSIS
      1. BUYERS POWER
      2. SUPPLIERS POWER
      3. SUBSTITUTION
      4. NEW ENTRANTS
      5. INDUSTRY RIVALRY
    4. OPPORTUNITY MATRIX
    5. VENDOR LANDSCAPE
  5. MARKET BY TYPE
    1. TYPE A
    2. TYPE B
  6. MARKET BY APPLICATION
    1. COSMETIC APPLICATIONS
      1. GLABELLAR LINES
      2. LATERAL CANTHAL LINES (CROW’S FEET)
      3. FOREHEAD LINES
      4. OTHER COSMETIC APPLICATIONS
    2. NON-COSMETIC APPLICATIONS
      1. DYSTONIA
      2. CHRONIC MIGRAINE
      3. OPHTHALMOLOGIC DISORDERS
      4. OTHER NON-COSMETIC APPLICATIONS
  7. MARKET BY END-USER
    1. HOSPITALS
    2. CLINICS AND OTHERS
  8. GEOGRAPHICAL ANALYSIS
    1. NORTH AMERICA
      1. KEY GROWTH ENABLERS
      2. KEY CHALLENGES
      3. KEY PLAYERS
      4. COUNTRY ANALYSIS
        1. UNITED STATES       
        2. CANADA         
    2. EUROPE
      1. KEY GROWTH ENABLERS
      2. KEY CHALLENGES
      3. KEY PLAYERS
      4. COUNTRY ANALYSIS
        1. UNITED KINGDOM    
        2. GERMANY      
        3. FRANCE          
        4. ITALY    
        5. RUSSIA
        6. BELGIUM         
        7. POLAND          
        8. REST OF EUROPE   
    3. ASIA-PACIFIC
      1. KEY GROWTH ENABLERS
      2. KEY CHALLENGES
      3. KEY PLAYERS
      4. COUNTRY ANALYSIS
        1. CHINA  
        2. JAPAN 
        3. INDIA    
        4. SOUTH KOREA         
        5. SINGAPORE   
        6. THAILAND       
        7. VIETNAM         
        8. AUSTRALIA & NEW ZEALAND      
        9. REST OF ASIA-PACIFIC      
    4. REST OF WORLD
      1. KEY GROWTH ENABLERS
      2. KEY CHALLENGES
      3. KEY PLAYERS
      4. REGIONAL ANALYSIS
        1. LATIN AMERICA        
        2. MIDDLE EAST & AFRICA    
  9. COMPETITIVE LANDSCAPE
    1. KEY STRATEGIC DEVELOPMENTS
      1. PRODUCT LAUNCHES & DEVELOPMENTS
    2. COMPANY PROFILES
      1. ABBVIE INC (ALLERGAN PLC)
      2. EVOLUS INC
      3. GALDERMA PHARMA SA (ACQUIRED BY EQT)
      4. HUGEL INC
      5. IPSEN PHARMA
      6. MEDYTOX INC
      7. MERZ PHARMA
      8. REVANCE THERAPEUTICS INC
      9. US WORLDMEDS LLC
LIST OF TABLES

TABLE 1: MARKET SNAPSHOT - BOTULINUM TOXIN

TABLE 2: GLOBAL BOTULINUM TOXIN MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 3: GLOBAL BOTULINUM TOXIN MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 4: GLOBAL TYPE A MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 5: GLOBAL TYPE A MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 6: GLOBAL TYPE B MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 7: GLOBAL TYPE B MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 8: GLOBAL BOTULINUM TOXIN MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 9: GLOBAL BOTULINUM TOXIN MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 10: GLOBAL COSMETIC APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 11: GLOBAL COSMETIC APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 12: GLOBAL BOTULINUM TOXIN MARKET, BY COSMETIC APPLICATIONS, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 13: GLOBAL BOTULINUM TOXIN MARKET, BY COSMETIC APPLICATIONS, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 14: GLOBAL GLABELLAR LINES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 15: GLOBAL GLABELLAR LINES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 16: GLOBAL LATERAL CANTHAL LINES (CROW’S FEET) MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 17: GLOBAL LATERAL CANTHAL LINES (CROW’S FEET) MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 18: GLOBAL FOREHEAD LINES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 19: GLOBAL FOREHEAD LINES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 20: GLOBAL OTHER COSMETIC APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 21: GLOBAL OTHER COSMETIC APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 22: GLOBAL NON-COSMETIC APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 23: GLOBAL NON-COSMETIC APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 24: GLOBAL BOTULINUM TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 25: GLOBAL BOTULINUM TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 26: GLOBAL DYSTONIA MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 27: GLOBAL DYSTONIA MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 28: GLOBAL CHRONIC MIGRAINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 29: GLOBAL CHRONIC MIGRAINE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 30: GLOBAL OPHTHALMOLOGIC DISORDERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 31: GLOBAL OPHTHALMOLOGIC DISORDERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 32: GLOBAL OTHER NON-COSMETIC APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 33: GLOBAL OTHER NON-COSMETIC APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 34: GLOBAL BOTULINUM TOXIN MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 35: GLOBAL BOTULINUM TOXIN MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 36: GLOBAL HOSPITALS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 37: GLOBAL HOSPITALS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 38: GLOBAL CLINICS AND OTHERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 39: GLOBAL CLINICS AND OTHERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 40: GLOBAL BOTULINUM TOXIN MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 41: GLOBAL BOTULINUM TOXIN MARKET, BY GEOGRAPHY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 42: NORTH AMERICA BOTULINUM TOXIN MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 43: NORTH AMERICA BOTULINUM TOXIN MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 44: EUROPE BOTULINUM TOXIN MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 45: EUROPE BOTULINUM TOXIN MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 46: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 47: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 48: REST OF WORLD BOTULINUM TOXIN MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 49: REST OF WORLD BOTULINUM TOXIN MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 50: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: OPPORTUNITY MATRIX

FIGURE 4: VENDOR LANDSCAPE

FIGURE 5: GLOBAL BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY TYPE, IN 2020

FIGURE 6: GLOBAL BOTULINUM TOXIN MARKET, BY TYPE A, 2021-2028 (IN $ MILLION)

FIGURE 7: GLOBAL BOTULINUM TOXIN MARKET, BY TYPE B, 2021-2028 (IN $ MILLION)

FIGURE 8: GLOBAL BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2020

FIGURE 9: GLOBAL BOTULINUM TOXIN MARKET, BY COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 10: GLOBAL BOTULINUM TOXIN MARKET, BY GLABELLAR LINES, 2021-2028 (IN $ MILLION)

FIGURE 11: GLOBAL BOTULINUM TOXIN MARKET, BY LATERAL CANTHAL LINES (CROW’S FEET), 2021-2028 (IN $ MILLION)

FIGURE 12: GLOBAL BOTULINUM TOXIN MARKET, BY FOREHEAD LINES, 2021-2028 (IN $ MILLION)

FIGURE 13: GLOBAL BOTULINUM TOXIN MARKET, BY OTHER COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 14: GLOBAL BOTULINUM TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 15: GLOBAL BOTULINUM TOXIN MARKET, BY DYSTONIA, 2021-2028 (IN $ MILLION)

FIGURE 16: GLOBAL BOTULINUM TOXIN MARKET, BY CHRONIC MIGRAINE, 2021-2028 (IN $ MILLION)

FIGURE 17: GLOBAL BOTULINUM TOXIN MARKET, BY OPHTHALMOLOGIC DISORDERS, 2021-2028 (IN $ MILLION)

FIGURE 18: GLOBAL BOTULINUM TOXIN MARKET, BY OTHER NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 19: GLOBAL BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY END-USER, IN 2020

FIGURE 20: GLOBAL BOTULINUM TOXIN MARKET, BY HOSPITALS, 2021-2028 (IN $ MILLION)

FIGURE 21: GLOBAL BOTULINUM TOXIN MARKET, BY CLINICS AND OTHERS, 2021-2028 (IN $ MILLION)

FIGURE 22: NORTH AMERICA BOTULINUM TOXIN MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

FIGURE 23: UNITED STATES BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)

FIGURE 24: CANADA BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)

FIGURE 25: EUROPE BOTULINUM TOXIN MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

FIGURE 26: UNITED KINGDOM BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)

FIGURE 27: GERMANY BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)

FIGURE 28: FRANCE BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)

FIGURE 29: ITALY BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)

FIGURE 30: RUSSIA BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)

FIGURE 31: BELGIUM BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)

FIGURE 32: POLAND BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)

FIGURE 33: REST OF EUROPE BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)

FIGURE 34: ASIA-PACIFIC BOTULINUM TOXIN MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

FIGURE 35: CHINA BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)

FIGURE 36: JAPAN BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)

FIGURE 37: INDIA BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)

FIGURE 38: SOUTH KOREA BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)

FIGURE 39: INDONESIA BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)

FIGURE 40: THAILAND BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)

FIGURE 41: VIETNAM BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)

FIGURE 42: AUSTRALIA & NEW ZEALAND BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)

FIGURE 43: REST OF ASIA-PACIFIC BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION

FIGURE 44: REST OF WORLD BOTULINUM TOXIN MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

FIGURE 45: LATIN AMERICA BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)

FIGURE 46: MIDDLE EAST & AFRICA BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)

Request For A Free Sample